Clinical Trial Update: SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis C [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating SH229 tablets in combination with daclatasvir dihydrochloride tablets for chronic hepatitis C is ongoing, with status curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• SH229 tablets
• daclatasvir dihydrochloride tablets (daclatasvir)

Snippet

Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. | Conditions: Hepatitis C, Chronic | Phase 2, Phase 3 | Status: UNKNOWN